Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.
about
Illustrating and homology modeling the proteins of the Zika virus.Galectin-1 exerts inhibitory effects during DENV-1 infectionSulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug DiscoveryPathogenesis and Inhibition of Flaviviruses from a Carbohydrate PerspectiveDengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeysProgress in the identification of dengue virus entry/fusion inhibitorsHighly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.Endothelial dysfunction in dengue virus pathology.New developments in flavivirus drug discovery.Characterization of in vitro dengue virus resistance to carrageenan.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Peptides as Therapeutic Agents for Dengue Virus.Molecular Responses of Human Retinal Cells to Infection with Dengue Virus.Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein.
P2860
Q27313484-7E6D433F-3ECC-4F3E-AD02-35B119EF7425Q28544937-6B4D9A54-C53D-4FE4-B05A-609B0AC05A22Q28817653-9D504ECF-3A53-4C41-BB74-8FB87C6A0C15Q29994529-5E74DA55-77E3-46D2-B0D4-7F00994145CCQ33800244-C4E24B9A-A346-47B2-90D4-DBBDF7F3007EQ34054616-C55E6656-80F4-4A06-A14F-A3EA1BE40F5CQ34057989-B49F9E63-D27D-4A64-9916-2C5E92233101Q37300431-89D93226-B2FE-4723-9029-08D55B9DD506Q38272173-DDDC34DD-02E8-474F-9B38-FE162D23DAADQ38769771-C76842E2-F32D-4D60-872B-19B21E68D9AAQ38809813-0374DEE6-C4B4-4ECF-AAA3-C424E5D07F87Q38866173-0737930F-B9E8-484A-9290-4223C3B89CC2Q45323856-BD25ACCF-41C7-4EAC-8828-9433C58745D5Q53126529-1AC911DD-A30D-4979-B93A-E63773F04FA7Q55209557-65F4C40C-ABF1-49F3-B420-B9A03F28996B
P2860
Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@ast
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@en
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@nl
type
label
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@ast
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@en
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@nl
prefLabel
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@ast
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@en
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@nl
P2093
P2860
P50
P921
P1433
P1476
Sulfated Escherichia coli K5 p ...... envelope protein E domain III.
@en
P2093
Marijke Alen
Pasqua Oreste
Sandra Liekens
P2860
P304
P356
10.1371/JOURNAL.PONE.0074035
P407
P577
2013-08-28T00:00:00Z